BayWa’s two largest shareholders, holding a combined 67% stake, are handing their shares to a trustee for an interim period, effectively ceding voting control of the beleaguered German agribusiness group. The move, part of a sweeping rescue plan that pushes the restructuring finish line to 2030, accompanies a crucial debt-to-equity conversion and a planned capital injection from the very same anchor investors. Against this backdrop, the company still has not published its audited 2025 annual report, leaving outsiders to fly blind on the true state of its finances.
Creditor banks are playing ball by agreeing to convert up to €700 million of existing loans into subordinated instruments, a step that bolsters equity without requiring fresh cash. In a parallel equity-raising plan targeted for 2029, the majority shareholders are expected to chip in at least €220 million. The combined measures aim to close a vast debt-reduction gap: BayWa needs to shed roughly €4 billion in liabilities but has locked in only €1.3 billion so far.
The group’s operational footprint is being radically redrawn. The future business will revolve around three core divisions – agriculture, technology and building materials – while the sale of the heating oil, diesel and lubricants trading unit is scheduled to be completed by the end of 2029, ending a years-long global expansion. The once-lauded renewables subsidiary BayWa r.e. is now a disappointment: the original €1.7 billion sale target has effectively been halved, with negotiations now revolving around €900 million. That revision blows a substantial hole in the cash-inflow assumptions underpinning the original rescue blueprint.
Should investors sell immediately? Or is it worth buying BayWa?
The stock market is reflecting deep unease. On Thursday, shares slid almost 5% to €10.90, leaving them more than a fifth below their long-term moving average of €15.03. Year-to-date, the equity has lost more than a third of its value, and volatility has spiked to 61%. The company’s entire market capitalisation stands at just €699 million – a sum dwarfed by the size of the asset disposals it is pursuing. Small wonder that every rumour about a sale or a creditor meeting sends the stock swinging wildly.
Three hard deadlines loom before autumn 2026. First, the current non-binding expression of interest from creditors must be converted into a legally binding restructuring agreement. Second, BayWa needs to sign off the audited financial statements for 2025 – a document that will not see the light of day until at least the fourth quarter of 2026, by which time the third milestone, the completion of the New Zealand-based T&G Global sale, must also be in the bag. Missing any one of those targets could unravel the entire rescue architecture and send the stock back towards its recent lows.
Ad
BayWa Stock: Buy or Sell?! New BayWa Analysis from July 9 delivers the answer:
The latest BayWa figures speak for themselves: Urgent action needed for BayWa investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 9.
BayWa: Buy or sell? Read more here...










